Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 2/2003

01-02-2003 | Original Article

Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients?

Authors: S. Schüttrumpf, L. Binder, T. Hagemann, D. Berkovic, L. Trümper, C. Binder

Published in: Annals of Hematology | Issue 2/2003

Login to get access
Metadata
Title
Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients?
Authors
S. Schüttrumpf
L. Binder
T. Hagemann
D. Berkovic
L. Trümper
C. Binder
Publication date
01-02-2003
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 2/2003
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-002-0584-y

Other articles of this Issue 2/2003

Annals of Hematology 2/2003 Go to the issue

Original Article

Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma: correlation with CD38/CD138 expressing myeloma cells

Case Report

Purpura fulminans in a child with combined heterozygous prothrombin G20210A and factor V Leiden mutations

Ongoing Clinical Studies

Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab

Original Article

Patients with biochemical iron overload: causes and characteristics of a cohort of 150 cases

Original Article

Incidence of thrombophilia detected in southern Taiwanese patients with venous thrombosis

Review Article

Malignant thymoma: current status of classification and multimodality treatment

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits